T Coquelle1, J K Christensen, T G Banke
1Neuroscience PharmaBiotec Research Center, Department of Pharmacology, The Royal Danish School of Pharmacy, Copenhagen.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed (S)-4-bromohomoibotenic acid (BrHIBO), a selective compound for AMPA receptors (AMPA-R). This novel molecule shows promise for developing targeted therapies by offering high selectivity for specific AMPA-R subtypes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: